Bridging Translation by Improving Preclinical Study Design in AKI
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Despite extensive research, no therapeutic interventions have been shown to prevent AKI, accelerate recovery of AKI, or reduce progression of AKI to CKD in patients. This failure in translation has led investigators to speculate that the animal models being used do not predict therapeutic responses in humans. Although this issue continues to be debated, an important concern that has not been addressed is whether improvements in preclinical study design can be identified that might also increase the likelihood of translating basic AKI research into clinical practice using the current models. In this review, we have taken an evidence-based approach to identify common weaknesses in study design and reporting in preclinical AKI research that may contribute to the poor translatability of the findings. We focused on use of N-acetylcysteine or sodium bicarbonate for the prevention of contrast-induced AKI and use of erythropoietin for the prevention of AKI, two therapeutic approaches that have been extensively studied in clinical trials. On the basis of our findings, we identified five areas for improvement in preclinical study design and reporting. These suggested and preliminary guidelines may help improve the quality of preclinical research for AKI drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
A call for transparent reporting to optimize the predictive value of preclinical research
Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., Fillit, H., et al. (2012) · Nature · doi:10.1038/nature11556 · Cited by 1,196
The economics of reproducibility in preclinical research
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055
Acute kidney injury: an increasing global concern
Lameire, N. H., Bagga, A., Cruz, D., De Maeseneer, J., Endre, Z., Kellum, J. A., Liu, K. D., Mehta, R. L., Pannu, N., Van Biesen, W., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60647-9 · Cited by 1,001
Self-citationAcute kidney injury-epidemiology, outcomes and economics
Rewa, O., & Bagshaw, S. M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.282 · Cited by 734
Translation of Research Evidence From Animals to Humans
Hackam, D. G., & Redelmeier, D. A. (2006) · JAMA · doi:10.1001/jama.296.14.1731 · Cited by 733
Cited by
Artificial intelligence in cardiology
Johnson, K. W., Torres Soto, J., Glicksberg, B. S., Shameer, K., Miotto, R., Ali, M., Ashley, E., & Dudley, J. T. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.521 · Cited by 1,202
Wu, H., Uchimura, K., Donnelly, E. L., Kirita, Y., Morris, S. A., & Humphreys, B. D. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.010 · Cited by 605
Self-citationUnderstanding and preventing contrast-induced acute kidney injury
Fähling, M., Seeliger, E., Patzak, A., & Persson, P. B. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.196 · Cited by 323
Immune cells and inflammation in AKI to CKD progression
Sato, Y., & Yanagita, M. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00195.2018 · Cited by 273
Bridging translation for acute kidney injury with better preclinical modeling of human disease
Skrypnyk, N. I., Siskind, L. J., Faubel, S., & de Caestecker, M. P. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00552.2015 · Cited by 61
Self-citation
Metadata
- Authors
- de Caestecker, M., Humphreys, B. D., Liu, K. D., Fissell, W. H., Cerda, J., Nolin, T. D., Askenazi, D., Mour, G., Harrell, F. E., Pullen, N., Okusa, M. D., & Faubel, S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-12
- Volume
- 26
- Issue
- 12
- Pages
- 2905-2916
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2195071417
- Cited by
- 99
- References
- 19
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bridging Translation by Improving Preclinical Study Design in AKI. https://app.cochat.ai/papers/10.1681/asn.2015070832
- The paper
- de Caestecker, M., Humphreys, B. D., Liu, K. D., Fissell, W. H., Cerda, J., Nolin, T. D., Askenazi, D., Mour, G., Harrell, F. E., Pullen, N., Okusa, M. D., & Faubel, S. (2015). Bridging Translation by Improving Preclinical Study Design in AKI. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2015070832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.